The CASP9 gene encodes Caspase-9, the initiator caspase of the intrinsic (mitochondrial) apoptosis pathway. Activated by the apoptosome, Caspase-9 initiates the caspase cascade that leads to executioner caspase activation and apoptotic cell death. It plays critical roles in neuronal survival, DNA damage response, and chemotherapy-induced cell death.
| Full Name | Caspase 9 |
|---|
| Chromosomal Location | 1p36.21 |
|---|
| NCBI Gene ID | 842 |
|---|
| OMIM | 602234 |
|---|
| Ensembl ID | ENSG00000132906 |
|---|
| UniProt | P55211 |
|---|
| Protein Class | Cysteine protease (initiator caspase) |
|---|
| Protein Size | 416 amino acids (~46 kDa) |
|---|
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Stroke, Brain Ischemia, Chemobrain, ALS |
|---|
Caspase-9 has a prodomain and catalytic domain:
- Caspase recruitment domain (CARD): N-terminal domain for Apaf-1 binding
- Catalytic domain: Contains the protease core with:
- Large subunit (p35)
- Small subunit (p11)
- Active site: Catalytic cysteine (C315) in motif QACXG
- Prodomain length: ~140 amino acids (long prodomain caspase)
- Apoptosome formation:
- Cytochrome c release from mitochondria
- Binds Apaf-1 in presence of dATP/ATP
- Oligomerization → apoptosome
- Procaspase-9 recruitment: CARD-CARD interaction with Apaf-1
- Autoactivation: Catalytic activation within apoptosome
- Caspase cascade:
- Activates executioner caspases (CASP3, CASP7)
- Leads to DNA fragmentation and cell death
- p53-mediated pathway: DNA damage activates p53 → PUMA/BAX → apoptosis
- Checkpoint activation: ATM/ATR kinases initiate repair or death
- PARP cleavage: CASP9 indirectly contributes through executioner caspases
- Apoptosis initiation: Central to mitochondrial apoptosis pathway
- Removal of damaged cells: Eliminates cells with mitochondrial dysfunction
- Regulation: Controlled by Bcl-2 family proteins
- Tissue distribution: Ubiquitous; high in brain, heart, liver
- Brain regions: Hippocampus, cerebral cortex, basal ganglia, cerebellum
- Cellular localization: Cytosol, mitochondrial intermembrane space
- Isoforms: Caspase-9a (full-length), Caspase-9b (alternate splice)
- Evidence: Elevated CASP9 activity in AD brain, especially in neurons
- Mechanism:
- Mitochondrial dysfunction triggers apoptosome formation
- Aβ induces cytochrome c release → CASP9 activation
- Contributes to synaptic loss and neuronal death
- Therapeutic target: Caspase-9 inhibitors for neuroprotection
- Evidence: Activated CASP9 in substantia nigra of PD patients
- Mechanism:
- Mitochondrial Complex I inhibition triggers apoptosis
- PINK1/PARKIN pathway links to CASP9 activation
- Dopaminergic neuron vulnerability
¶ Stroke and Brain Ischemia
- Evidence: Rapid CASP9 activation following ischemic injury
- Mechanism:
- Reperfusion triggers massive mitochondrial damage
- Cyt cytochrome c release → apoptosome → CASP9
- Contributes to infarct expansion
- Therapeutic target: Neuroprotective strategies
- Evidence: CASP9 activation in neurons after chemotherapy
- Mechanism:
- Chemotherapy agents damage neuronal mitochondria
- Leads to cognitive dysfunction
- Prevention: Caspase inhibitors in development
- Evidence: CASP9 activation in motor neurons of ALS patients
- Mechanism:
- Mitochondrial dysfunction in ALS
- Links to SOD1 and C9orf72 mutations
Caspase-9 interacts with:
- Apaf-1: Central to apoptosome formation
- Cytochrome c: Released from mitochondria to trigger pathway
- dATP/ATP: Required for apoptosome assembly
- BCL2 family: Regulated by anti-apoptotic (BCL2, BCL-XL) and pro-apoptotic (BAX, BAK) proteins
- XIAP: Inhibitor of apoptosis protein that directly inhibits CASP9
- Smac/DIABLO: IAP antagonist released with cytochrome c
- Executioner caspases (CASP3, CASP7): Downstream targets
- Z-LEHD-FMK: Selective CASP9 inhibitor (experimental)
- X-linked IAP (XIAP) antagonists: Smac mimetics
- Mitochondrial protectants: CoQ10, MitoQ
- Apoptosis modulators:BCL2 family targeting
- Knockout mice: Viable but develop brain abnormalities
- Knockin models: Specific mutations to study activation
-
Li P, et al. (1997). "Cytochrome c and dATP-dependent formation of Apaf-1." Cell. PMID:9228950 — Discovery of apoptosome.
-
Rodriguez J, Lazebnik Y. (1999). "Caspase-9 and APAF-1." Cell. PMID:10374899 — Apoptosome function.
-
Yuan J, et al. (1993). "Caspases and apoptosis." Cell. PMID:8252622 — Early caspase research.
-
Riedl SJ, et al. (2004). "Structure of caspase-9." Nat Struct Biol. PMID:15227960 — Structural basis.
-
Matsuzawa A, Ichijo H. (2008). "Redox regulation." Free Radic Biol Med. PMID:18328253 — Redox regulation of apoptosis.
The study of Casp9 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.